Literature DB >> 2105270

Localization of the cleavage site specificity determinant of Haemophilus influenzae immunoglobulin A1 protease genes.

F J Grundy1, A G Plaut, A Wright.   

Abstract

Immunoglobulin A1 (IgA1) proteases are produced by a number of different species of bacteria which cause infection at human mucosal surfaces. The sole substrate of these proteases is human IgA1. Cleavage is within the hinge region of IgA1, although there is variability in the exact peptide bond within the hinge region that is cut by a particular protease. The cleavage site of the Haemophilus influenzae type 1 protease is located four amino acids from the cleavage site of the type 2 enzyme. In this study, the region of the H. influenzae IgA1 protease gene (iga) that determines the cleavage site specificity was localized through the comparison of the type 1 and type 2 genes and the construction and analysis of type 1-type 2 hybrid genes. The hybrid genes were generated by in vivo and in vitro techniques which facilitated the selection and screening of randomly generated hybrids. The cleavage site determinant was found to be within a 370-base-pair region near the amino-terminal coding region, in one of two large areas of nonhomology between the two types of H. influenzae iga genes. DNA sequence analysis of the cleavage site determinant and surrounding regions did not reveal a simple mechanism whereby one enzyme type could be converted to the other type. Comparison of the type 2 gonococcal IgA1 protease gene to the two Haemophilus genes revealed a significant amount of homology around the cleavage site determinant, with the two type 2 genes showing greater homology.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105270      PMCID: PMC258458          DOI: 10.1128/iai.58.2.320-331.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Haemophilus influenzae immunoglobulin A1 protease genes: cloning by plasmid integration-excision, comparative analyses, and localization of secretion determinants.

Authors:  F J Grundy; A Plaut; A Wright
Journal:  J Bacteriol       Date:  1987-10       Impact factor: 3.490

2.  Prophage deletion mapping of bacteriophage Mu-1.

Authors:  M M Howe
Journal:  Virology       Date:  1973-07       Impact factor: 3.616

3.  Defined nongrowth media for stage II development of competence in Haemophilus influenzae.

Authors:  R M Herriott; E M Meyer; M Vogt
Journal:  J Bacteriol       Date:  1970-02       Impact factor: 3.490

4.  Detection of IgA protease activity among multiple bacterial colonies.

Authors:  J V Gilbert; A G Plaut
Journal:  J Immunol Methods       Date:  1983-02-25       Impact factor: 2.303

5.  Rapid and efficient cosmid cloning.

Authors:  D Ish-Horowicz; J F Burke
Journal:  Nucleic Acids Res       Date:  1981-07-10       Impact factor: 16.971

Review 6.  The IgA1 proteases of pathogenic bacteria.

Authors:  A G Plaut
Journal:  Annu Rev Microbiol       Date:  1983       Impact factor: 15.500

7.  Analysis of gene control signals by DNA fusion and cloning in Escherichia coli.

Authors:  M J Casadaban; S N Cohen
Journal:  J Mol Biol       Date:  1980-04       Impact factor: 5.469

8.  Immunoglobulin A1 protease production by Haemophilus influenzae and Streptococcus pneumoniae.

Authors:  C J Male
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

9.  Differential susceptibility of human IgA immunoglobulins to streptococcal IgA protease.

Authors:  A G Plaut; R Wistar; J D Capra
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

10.  Induction of streptomycin resistance in sensitive Hemophilus influenzae by extracts containing desoxyribonucleic acid from resistant Hemophilus influenzae.

Authors:  H E ALEXANDER; G LEIDY
Journal:  J Exp Med       Date:  1953-01       Impact factor: 14.307

View more
  9 in total

1.  Cleavage of a recombinant human immunoglobulin A2 (IgA2)-IgA1 hybrid antibody by certain bacterial IgA1 proteases.

Authors:  B W Senior; J I Dunlop; M R Batten; M Kilian; J M Woof
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Characterization of pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coli.

Authors:  I R Henderson; J Czeczulin; C Eslava; F Noriega; J P Nataro
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  Characterization of igaB, a second immunoglobulin A1 protease gene in nontypeable Haemophilus influenzae.

Authors:  Matthew M Fernaays; Alan J Lesse; Xueya Cai; Timothy F Murphy
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

4.  Comparative analysis of immunoglobulin A1 protease activity among bacteria representing different genera, species, and strains.

Authors:  J Reinholdt; M Kilian
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

5.  Antigenic relationships among immunoglobulin A1 proteases from Haemophilus, Neisseria, and Streptococcus species.

Authors:  H Lomholt; M Kilian
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Distinct antigenic and genetic properties of the immunoglobulin A1 protease produced by Haemophilus influenzae biogroup aegyptius associated with Brazilian purpuric fever in Brazil.

Authors:  H Lomholt; M Kilian
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

7.  Analysis of the specificity of bacterial immunoglobulin A (IgA) proteases by a comparative study of ape serum IgAs as substrates.

Authors:  J Qiu; G P Brackee; A G Plaut
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

8.  A comparative genetic study of serologically distinct Haemophilus influenzae type 1 immunoglobulin A1 proteases.

Authors:  K Poulsen; J Reinholdt; M Kilian
Journal:  J Bacteriol       Date:  1992-05       Impact factor: 3.490

Review 9.  Vaccine Candidates against Nontypeable Haemophilus influenzae: a Review

Authors:  Ava Behrouzi; Fatemeh Rahimi-Jamnani; Seyed Davar Siadat
Journal:  Iran Biomed J       Date:  2017-03-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.